Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dauntless-1: PMD-026 in RSK2+ Advanced Breast Cancer
NCT04115306Phase 2Active, not recruiting
- Sponsor
- Phoenix Molecular Designs
- Start
- Nov 2019
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of PMD-026 in breast cancer, sponsored by Phoenix Molecular Designs. Started Nov 2019; status: active, not recruiting.
02
Drugs
PMD-026
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT04115306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04115306.